Lab-grown hearts with immune cells develop atrial fibrillation after chronic inflammation, offering a new way to test ...
News Medical on MSN
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with Cherry ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果